Sentinel lymph node biopsy (SLNB) is the standard of care for axillary staging in clinically
node-negative (cN0) breast cancer patients without neoadjuvant chemotherapy (NAC). The …

Sentinel lymph node biopsy (SLNB) is widely employed to detect axillary lymph node
metastases in breast cancer patients with clinically negative (N0) axillae. One of the few …

Introduction Several studies have assessed the feasibility of sentinel lymph node biopsy
(SLNB) after NAC in patients with breast cancer, but diagnostic accuracy has varied. We …

Breast cancer patients who present with nodal metastasis receive neoadjuvant
chemotherapy (NAC) with increasing frequency and can have complete pathologic …

Despite the widespread use of sentinel lymph node biopsy (SLNBx) in the surgical
management of breast cancer patients, several areas remain controversial. The following …

BACKGROUND: Several authors reported sentinel lymph node biopsy (SLNB) after
neoadjuvant chemotherapy (NC). Nevertheless, the ideal time of SLNB is still a matter of …

Simple Summary Axillary status is crucial for determining the correct local and systemic
treatment. The possibility of de-escalating axillary surgery in patients with breast cancer …

BACKGROUND: Sentinel lymph node biopsy (SLNB) is a widely used staging method for
patients with early breast cancer. Neoadjuvant chemotherapy modifies the anatomical …

Background Despite the widespread application of sentinel lymph node biopsy (SLNB) for
early stage breast cancer, there is a wide variation in reported test performance …

Purpose Sentinel lymph node biopsy (SLNB) is an accurate and effective means of axillary
nodal staging in early breast cancer. However its indication after neoadjuvant chemotherapy …